Detalles de la búsqueda
1.
Management of Medullary Thyroid Cancer: Patterns of Recurrence and Outcomes of Reoperative Surgery.
Oncologist;
28(12): 1064-1071, 2023 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37632760
2.
A Detailed Histologic and Molecular Assessment of the Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma.
Mod Pathol;
36(12): 100329, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37716505
3.
Genotype-Phenotype Correlations and Clinical Outcomes in 155 Cases of Pheochromocytoma and Paraganglioma.
World J Surg;
47(3): 690-698, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36550325
4.
Outcomes of Advanced Medullary Thyroid Carcinoma in the Era of Targeted Therapy.
Ann Surg Oncol;
29(1): 64-71, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34716515
5.
Multimodality Treatment Improves Locoregional Control, Progression-Free and Overall Survival in Patients with Anaplastic Thyroid Cancer: A Retrospective Cohort Study Comparing Oncological Outcomes and Morbidity between Multimodality Treatment and Limited Treatment.
Ann Surg Oncol;
28(12): 7520-7530, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34032961
6.
The Significance of Histologically "Large Normal" Parathyroid Glands in Primary Hyperparathyroidism.
World J Surg;
44(4): 1149-1155, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31773224
7.
Disease Progression in Papillary Thyroid Cancer with Biochemical Incomplete Response to Initial Therapy.
Ann Surg Oncol;
24(9): 2611-2616, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28585075
8.
Correction to: Multimodality Treatment Improves Locoregional Control, Progression-Free and Overall Survival in Patients with Anaplastic Thyroid Cancer: A Retrospective Cohort Study Comparing Oncological Outcomes and Morbidity between Multimodality Treatment and Limited Treatment.
Ann Surg Oncol;
28(Suppl 3): 891, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34279756
9.
Characteristics of contralateral carcinomas in patients with differentiated thyroid cancer larger than 1 cm.
Langenbecks Arch Surg;
401(3): 365-73, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27013326
10.
Minimally invasive adrenalectomy: a cohort study of surgical approach and outcomes.
ANZ J Surg;
93(9): 2222-2228, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37132079
11.
Lobectomy and completion thyroidectomy rates increase after the 2015 American Thyroid Association Differentiated Thyroid Cancer Guidelines update.
Endocr Oncol;
3(1): e220095, 2023 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37434647
12.
Tumour volume is a predictor of lymphovascular invasion in differentiated small thyroid cancer.
Endocr Oncol;
2(1): 42-49, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37435463
13.
Change in Practice of Radioactive Iodine Administration in Differentiated Thyroid Cancer: A Single-Centre Experience.
Eur Thyroid J;
10(5): 408-415, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34540711
14.
Prophylactic central lymph node dissection informs the decision of radioactive iodine ablation in papillary thyroid cancer.
Am J Surg;
221(5): 886-892, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32878695
15.
Predicting distant metastatic disease in differentiated thyroid cancer: a matched case-control study.
ANZ J Surg;
91(4): 716-723, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33590959
16.
Early postoperative stimulated serum thyroglobulin quantifies risk of recurrence in papillary thyroid cancer.
Surgery;
167(1): 40-45, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31515121
17.
Surgery alone for papillary thyroid microcarcinoma is less costly and more effective than long term active surveillance.
Surgery;
167(1): 110-116, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31543327
18.
NRASQ61R Mutation-specific Immunohistochemistry Also Identifies the HRASQ61R Mutation in Medullary Thyroid Cancer and May Have a Role in Triaging Genetic Testing for MEN2.
Am J Surg Pathol;
41(1): 75-81, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27635947
19.
An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer.
Thyroid;
26(3): 373-80, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26914539
20.
Oxyphil Cell Parathyroid Adenomas Causing Primary Hyperparathyroidism: a Clinico-Pathological Correlation.
Endocr Pathol;
26(3): 250-4, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26091632